Why is this the case? Why have we not advanced beyond hybridoma-based monoclonal and polyclonal antibody production practices? Aren't there any alternatives? Actually, there have been for quite a ...

The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...

Antibodies bind to specific antigens on pathogens. This means that only one type of antibody will bind to a matching antigen. Scientists discovered that we could make antibodies to bind to ...

‘Mono’ means one and 'clone' means identical copy. Monoclonal antibodies are, therefore, identical copies of one type of antibody. Antibodies bind to specific antigens on pathogens. This means ...

GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immunodeficiencies, infectious diseases and checkpoint-resistant cancers, and a subsidiary of Grifols, announced today ...

French pharma major Sanofi today announced an investment of 40 million euros ($42.4 million) in its Lyon Gerland ...